Cargando…
Recommended immunization schedule for children and adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018
The Committee on Infectious Diseases of the Korean Pediatric Society recommended immunization schedule for children and adolescents aged 18 years or younger in the 9th (2018) edition of Immunization guideline. This report provides the revised recommendations made by the committee and summarizes seve...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642926/ https://www.ncbi.nlm.nih.gov/pubmed/31163961 http://dx.doi.org/10.3345/kjp.2019.00227 |
_version_ | 1783437054143627264 |
---|---|
author | Choi, Eun Hwa Park, Su Eun Kim, Yae-Jean Jo, Dae Sun Kim, Yun-Kyung Eun, Byung-Wook Lee, Taek-Jin Lee, Jina Lee, Hyunju Kim, Ki Hwan Cho, Hye-Kyung Cho, Eun Young Kim, Jong-Hyun |
author_facet | Choi, Eun Hwa Park, Su Eun Kim, Yae-Jean Jo, Dae Sun Kim, Yun-Kyung Eun, Byung-Wook Lee, Taek-Jin Lee, Jina Lee, Hyunju Kim, Ki Hwan Cho, Hye-Kyung Cho, Eun Young Kim, Jong-Hyun |
author_sort | Choi, Eun Hwa |
collection | PubMed |
description | The Committee on Infectious Diseases of the Korean Pediatric Society recommended immunization schedule for children and adolescents aged 18 years or younger in the 9th (2018) edition of Immunization guideline. This report provides the revised recommendations made by the committee and summarizes several changes from the 2015 guideline. National immunization program (NIP) launched a human papillomavirus (HPV) immunization for girls aged 12 years in 2016. NIP has also expanded age indication for inactivated influenza vaccine (IIV) to 12 years of age in the 2018-2019 season. Quadrivalent IIVs with a full dose (0.5 mL) are approved for all children of 6 months or older. Recommendations of live attenuated influenza vaccine were removed. For inactivated Japanese encephalitis vaccine, first 2 doses are considered as the primary series. Recommendations for use of newly introduced vaccines (diphtheria-tetanus-acellular pertussis/inactivated poliovirus/Haemophilus influenzae type b, 9-valent HPV, new varicella vaccine, new quadrivalent IIV, and attenuated oral typhoid vaccine) were added. Lastly, monitoring system for adverse events following immunization was updated. Other changes can be found in the 9th edition of Immunization guideline in detail. |
format | Online Article Text |
id | pubmed-6642926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Korean Pediatric Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-66429262019-07-29 Recommended immunization schedule for children and adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018 Choi, Eun Hwa Park, Su Eun Kim, Yae-Jean Jo, Dae Sun Kim, Yun-Kyung Eun, Byung-Wook Lee, Taek-Jin Lee, Jina Lee, Hyunju Kim, Ki Hwan Cho, Hye-Kyung Cho, Eun Young Kim, Jong-Hyun Korean J Pediatr Review Article The Committee on Infectious Diseases of the Korean Pediatric Society recommended immunization schedule for children and adolescents aged 18 years or younger in the 9th (2018) edition of Immunization guideline. This report provides the revised recommendations made by the committee and summarizes several changes from the 2015 guideline. National immunization program (NIP) launched a human papillomavirus (HPV) immunization for girls aged 12 years in 2016. NIP has also expanded age indication for inactivated influenza vaccine (IIV) to 12 years of age in the 2018-2019 season. Quadrivalent IIVs with a full dose (0.5 mL) are approved for all children of 6 months or older. Recommendations of live attenuated influenza vaccine were removed. For inactivated Japanese encephalitis vaccine, first 2 doses are considered as the primary series. Recommendations for use of newly introduced vaccines (diphtheria-tetanus-acellular pertussis/inactivated poliovirus/Haemophilus influenzae type b, 9-valent HPV, new varicella vaccine, new quadrivalent IIV, and attenuated oral typhoid vaccine) were added. Lastly, monitoring system for adverse events following immunization was updated. Other changes can be found in the 9th edition of Immunization guideline in detail. Korean Pediatric Society 2019-07 2019-07-15 /pmc/articles/PMC6642926/ /pubmed/31163961 http://dx.doi.org/10.3345/kjp.2019.00227 Text en Copyright © 2019 by The Korean Pediatric Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Choi, Eun Hwa Park, Su Eun Kim, Yae-Jean Jo, Dae Sun Kim, Yun-Kyung Eun, Byung-Wook Lee, Taek-Jin Lee, Jina Lee, Hyunju Kim, Ki Hwan Cho, Hye-Kyung Cho, Eun Young Kim, Jong-Hyun Recommended immunization schedule for children and adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018 |
title | Recommended immunization schedule for children and adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018 |
title_full | Recommended immunization schedule for children and adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018 |
title_fullStr | Recommended immunization schedule for children and adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018 |
title_full_unstemmed | Recommended immunization schedule for children and adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018 |
title_short | Recommended immunization schedule for children and adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018 |
title_sort | recommended immunization schedule for children and adolescents: committee on infectious diseases of the korean pediatric society, 2018 |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642926/ https://www.ncbi.nlm.nih.gov/pubmed/31163961 http://dx.doi.org/10.3345/kjp.2019.00227 |
work_keys_str_mv | AT choieunhwa recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 AT parksueun recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 AT kimyaejean recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 AT jodaesun recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 AT kimyunkyung recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 AT eunbyungwook recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 AT leetaekjin recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 AT leejina recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 AT leehyunju recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 AT kimkihwan recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 AT chohyekyung recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 AT choeunyoung recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 AT kimjonghyun recommendedimmunizationscheduleforchildrenandadolescentscommitteeoninfectiousdiseasesofthekoreanpediatricsociety2018 |